Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction

ConclusionInitiation of sacubitril/valsartan is associated with a lower degree of VT/VF, resulting in less ICD-interventions. This beneficial effect on ventricular arrhythmias might be related to cardiac reverse remodeling.

http://link.springer.com/10.1007/s00392-019-01440-y

Source: Clinical Research in Cardiology - February 20, 2019 Category: Cardiology Source Type: research